Meeting
2023 ASCO Gastrointestinal Cancers Symposium
The impact of peri-operative chemotherapy on the outcomes of patients with non-metastatic cholangiocarcinoma.
Authors
Firas Baidoun
Hematology Oncology Division, Mayo Clinic-Florida, Jacksonville, FL;
Firas Baidoun , Muhamad Alhaj Moustafa , Omar Abdel-Rahman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract
Track
Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 41, 2023 (suppl 4; abstr 563)
DOI
10.1200/JCO.2023.41.4_suppl.563
Abstract #
563
Poster Bd #
D15
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Neoadjuvant hypofractionated radiotherapy combined with pembrolizumab plus chemotherapy for potentially resectable non-small cell lung cancer: A phase Ib study.
First Author: Naixin Ding
Poster
2021 ASCO Annual Meeting
Use of circulating tumor DNA in colorectal cancer patients to assess tumor burden and response to therapy: An observational study.
First Author: Erin L. Symonds
Poster
2020 ASCO Virtual Scientific Program
Checkmate 77T: A phase III trial of neoadjuvant nivolumab (NIVO) plus chemotherapy (chemo) followed by adjuvant nivo in resectable early-stage NSCLC.
First Author: Tina Cascone
Poster
2020 Genitourinary Cancers Symposium
Sequencing chemotherapy and surgery in upper tract urothelial cancers.
First Author: Saurabh Parasramka